The urgent need for evidence on measures to respond to the COVID-19 pandemic had led to a
rapid escalation in numbers of studies testing potential therapeutic options. The vast amount of
data generated by these studies must be interpreted quickly so that physicians have the
information to make optimal tr...
The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. This new information must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines m...
This is the fourteenth edition of this database of evidence on potential therapeutic options for COVID-19, in which 68 therapeutic options are examined. This information will help investigators, policy makers, and prescribers navigate the flood of relevant data to ensure that management of COVID-19, at b...
This is the thirteenth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined....
This is the twelfth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined. Th...
This is the twelfth edition of this summary of rapid systematic reviews, which includes the results of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 58 therapeutic options are examined. Th...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Betacoronavirus/drug effects,
Adrenal Cortex Hormones/therapeutic use,
Ribavirin/therapeutic use,
Mesenchymal Stem Cells,
Hydroxychloroquine/therapeutic use,
Mycophenolic Acid/therapeutic use,
Tacrolimus/therapeutic use,
Prednisolone/therapeutic use,
Meropenem/therapeutic use,
Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use,
Folic Acid/therapeutic use,
Ursodeoxycholic Acid/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Chloroquine/therapeutic use,
Interferon-alpha/therapeutic use,
Azithromycin/therapeutic use,
Immunoglobulins/therapeutic use,
Antibodies, Monoclonal/therapeutic use,
Antibodies, Neutralizing/therapeutic use,
Technology Assessment, Biomedical,
Cohort Studies,
Cross-Sectional Studies
